UB Paderborn / Katalog / Suche / in CDI

ABCB1 genetic variants in leukemias: current insights into treatment outcomes

Pharmacogenomics and personalized medicine, 2017-01, Vol.10, p.169-181

Ankathil, Ravindran

2017

Link zum Volltext

Verfügbarkeit prüfen

Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes

Tumor biology, 2015-09, Vol.36 (9), p.6633-6644

2015

Link zum Volltext

Verfügbarkeit prüfen

Genetic variations in influx transporter gene SLC22A1 are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients

Journal of genetics, 2018-09, Vol.97 (4), p.835-842

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacogenetics and the treatment of chronic myeloid leukemia: how relevant clinically? An update

Pharmacogenomics, 2018-04, Vol.19 (5), p.475-393

2018

Link zum Volltext

Verfügbarkeit prüfen

Screening of 22q11.2DS Using Multiplex Ligation-Dependent Probe Amplification as an Alternative Diagnostic Method

BioMed research international, 2020-09, Vol.2020, p.6945730-6

2020

Link zum Volltext

Verfügbarkeit prüfen

Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate

Frontiers in oncology, 2022-08, Vol.12, p.720845-720845

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen

International journal of breast cancer, 2020, Vol.2020, p.8424365-8

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of CYP3A418 and CYP3A53 Polymorphisms on Imatinib Mesylate Response Among Chronic Myeloid Leukemia Patients in Malaysia

Oncology and therapy, 2016-12, Vol.4 (2), p.303-314

2016

Link zum Volltext

Verfügbarkeit prüfen

Hyperdiploid Multiple Myeloma with Novel Complex Structural Chromosome Abnormalities Associated with Poor Prognosis : A Rare Case Report

International journal of hematology- oncology and stem cell research, 2021-07, Vol.15 (3), p.199-205

2021

Link zum Volltext

Verfügbarkeit prüfen

Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients

Cardiovascular & hematological disorders drug targets, 2018, Vol.18 (3), p.234

2018

Link zum Volltext

Verfügbarkeit prüfen

Single-nucleotide polymorphisms and mRNA expression of CYP1B1 influence treatment response in triple negative breast cancer patients undergoing chemotherapy

Journal of genetics, 2018-12, Vol.97 (5), p.1185-1194

2018

Link zum Volltext

Verfügbarkeit prüfen

ABCB1 genetic variants in leukemias: current insights into treatment outcomes

Pharmacogenomics and personalized medicine, 2020-03, p.169

Ankathil, Ravindran

2020

Link zum Volltext

Verfügbarkeit prüfen

Risk modification of colorectal cancer susceptibility by interleukin-8-251T〉A polymorphism in Malaysians

World journal of gastroenterology : WJG, 2012-06, Vol.18 (21), p.2668-2673

2012

Link zum Volltext

Verfügbarkeit prüfen

Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India

Journal of cancer research and clinical oncology, 2008-06, Vol.134 (6), p.645-652

2008

Link zum Volltext

Verfügbarkeit prüfen

Tobacco, Genetic Susceptibility and Lung Cancer

Tobacco Use Insights, 2010-01, Vol.2010 (3), p.1

Ankathil, Ravindran

2010

Link zum Volltext

Verfügbarkeit prüfen

p53 Arg72Pro Polymorphism Predicts Survival Outcome in Lung Cancer Patients in Indian Population

Cancer investigation, 2008-01, Vol.26 (1), p.41-46

2008

Link zum Volltext

Verfügbarkeit prüfen

OP0015 Polymorphisms in apoptosis-related genes and risk of HPV-mediated cervical cancer: A case-control study

European journal of cancer (1990), 2015-07, Vol.51, p.e4-e5

2015

Link zum Volltext

Verfügbarkeit prüfen

Gene therapy: An updated overview on the promising success stories

Malaysian journal of pathology, 2020-08, Vol.42 (2), p.171-185

2020

Link zum Volltext

Verfügbarkeit prüfen

Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy

Asian Pacific journal of cancer prevention : APJCP, 2022-03, Vol.23 (3), p.1053-1059

2022

Link zum Volltext

Verfügbarkeit prüfen

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients

Hematology reports, 2012-11, Vol.4 (4), p.e23-e23

2012

Link zum Volltext

Verfügbarkeit prüfen

Association of ABCG2 Polymorphisms on Triple Negative Breast Cancer (TNBC) Susceptibility Risk

Asian Pacific journal of cancer prevention : APJCP, 2023-11, Vol.24 (11), p.3891-3897

2023

Link zum Volltext

Verfügbarkeit prüfen

P0172Clinical relevance of a pharmacogenetic approach using multiple transporter genes to predict response and resistance to imatinib therapy in Malaysian patients with chronic myeloid leukaemia

European journal of cancer (1990), 2015-07, Vol.51, p.e33-e33

2015

Link zum Volltext

Verfügbarkeit prüfen

Novel germline mutations in BRCA2 gene among 96 hereditary breast and breast-ovarian cancer families from Kerala, South India

Journal of cancer research and clinical oncology, 2007-11, Vol.133 (11), p.867-874

2007

Link zum Volltext

Verfügbarkeit prüfen

Association of GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms with clinical response to imatinib mesylate treatment among Malaysian chronic myeloid leukaemia patients

Journal of genetics, 2017-09, Vol.96 (4), p.633-639

2017

Link zum Volltext

Verfügbarkeit prüfen

Vascular Endothelial Growth Factor Receptor Polymorphisms and im Treatment Response in Chronic Myeloid Leukemia Patients

Annals of oncology, 2019-10, Vol.30, p.vi110-vi111

2019

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

ABCB1 genetic variants in leukemias: current insights into treatment outcomes

Genetic susceptibility to cervical cancer: role of common polymorphisms in apoptosis-related genes

Genetic variations in influx transporter gene SLC22A1 are associated with clinical responses to imatinib mesylate among Malaysian chronic myeloid leukaemia patients

Pharmacogenetics and the treatment of chronic myeloid leukemia: how relevant clinically? An update

Screening of 22q11.2DS Using Multiplex Ligation-Dependent Probe Amplification as an Alternative Diagnostic Method

Differential prognostic impact of stratified additional chromosome abnormalities on disease progression among Malaysian chronic myeloid leukemia patients undergoing treatment with imatinib mesylate

Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen

Impact of CYP3A418 and CYP3A53 Polymorphisms on Imatinib Mesylate Response Among Chronic Myeloid Leukemia Patients in Malaysia

Hyperdiploid Multiple Myeloma with Novel Complex Structural Chromosome Abnormalities Associated with Poor Prognosis : A Rare Case Report

Aberrant DNA Methylation of SOCS1 Gene is Not Associated with Resistance to Imatinib Mesylate among Chronic Myeloid Leukemia Patients

Single-nucleotide polymorphisms and mRNA expression of CYP1B1 influence treatment response in triple negative breast cancer patients undergoing chemotherapy

ABCB1 genetic variants in leukemias: current insights into treatment outcomes

Risk modification of colorectal cancer susceptibility by interleukin-8-251T〉A polymorphism in Malaysians

Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India

Tobacco, Genetic Susceptibility and Lung Cancer

p53 Arg72Pro Polymorphism Predicts Survival Outcome in Lung Cancer Patients in Indian Population

OP0015 Polymorphisms in apoptosis-related genes and risk of HPV-mediated cervical cancer: A case-control study

Gene therapy: An updated overview on the promising success stories

Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy

Contribution of BCR-ABL kinase domain mutations to imatinib mesylate resistance in Philadelphia chromosome positive Malaysian chronic myeloid leukemia patients

Association of ABCG2 Polymorphisms on Triple Negative Breast Cancer (TNBC) Susceptibility Risk

P0172Clinical relevance of a pharmacogenetic approach using multiple transporter genes to predict response and resistance to imatinib therapy in Malaysian patients with chronic myeloid leukaemia

Novel germline mutations in BRCA2 gene among 96 hereditary breast and breast-ovarian cancer families from Kerala, South India

Association of GSTM1, GSTT1 and GSTP1 Ile105Val polymorphisms with clinical response to imatinib mesylate treatment among Malaysian chronic myeloid leukaemia patients

Vascular Endothelial Growth Factor Receptor Polymorphisms and im Treatment Response in Chronic Myeloid Leukemia Patients

Suchergebnisse filtern